Home › Alzheimer's Disease › Ohio › Parma
Alzheimer's Disease clinical trials in Parma, OH
4 studies for Alzheimer's Disease are looking for participants at sites in and around Parma (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
RecruitingPhase 2
- Clinical Site, Independence · 5 mi away
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
RecruitingPhase 3
- Insight Clinical Trials LLC - Independence, Independence · 5 mi away
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
RecruitingPhase 2
- Insight Clinical Trials ( Site 1011), Independence · 5 mi away
A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)
RecruitingPhase 3
- Insight Clinical Trials LLC - Independence, Independence · 5 mi away
About Alzheimer's Disease
Alzheimer's disease is a brain disorder that slowly destroys memory and thinking skills. It's the most common cause of dementia among older adults.
More about Alzheimer's Disease on MedlinePlus
Alzheimer's Disease trials in other cities
- Orlando, FL29 studies
- Boston, MA28 studies
- St. Louis, MO22 studies
- Miami, FL21 studies
- New York City, NY21 studies
- Tampa, FL20 studies
- Atlanta, GA19 studies
- The Villages, FL18 studies
- Phoenix, AZ15 studies
- West Palm Beach, FL15 studies
- Los Angeles, CA14 studies
- Philadelphia, PA14 studies
Other studies in Parma
- Ulcerative Colitis9 studies
- Steatotic Liver Disease8 studies
- Crohn's Disease6 studies
- Schizophrenia5 studies
- Lung Cancer5 studies
- Ovarian Cancer4 studies
- Psychotic Disorders4 studies
- Endometrial Cancer4 studies
- Major Depressive Disorder4 studies
- Cancer (all types)3 studies
- Lupus3 studies
- Non-Small Cell Lung Cancer3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.